Effectiveness of BCG vaccination against Mycobacterium tuberculosis infection in adults: a cross-sectional analysis of a UK-based cohort

Bacterial InfectionsViral Infections, Non-HIV

Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis

Vaccine.

Levillain F, Kim H, Woong Kwon K, Clark S, Cia F, Malaga W, Lanni F, Brodin P, Gicquel B, Guilhot C, Bancroft GJ, Williams A, Jae Shin S, Poquet Y, Neyrolles O

doi: 10.1016/j.vaccine.2019.11.085.

Bacterial InfectionsViral Infections, Non-HIV

Does BCG Vaccination Protect Against Non-Tuberculous Mycobacterial Infection? A Systematic Review and Meta-Analysis

J Infect Dis.

Zimmermann P, Finn A, Curtis N

doi: 10.1093/infdis/jiy207.

Viral Infections, Non-HIV

Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: A population survey-based cross-sectional analysis

Vaccine

Closson K, Karim ME, Sadarangani M, Naus M, Ogilvie GS, Donken R

doi: 10.1016/j.vaccine.2020.10.033

Mycobacterial Infections

Trained innate immunity and resistance to Mycobacterium tuberculosis infection

Clin Microbiol Infect.

Koeken VA, Verrall AJ, Netea MG, Hill PC, van Crevel R

doi: 10.1016/j.cmi.2019.02.015.

Viral Infections, Non-HIV

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons

Vaccine.

Russell K, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Flannery B

doi: 10.1016/j.vaccine.2018.01.045.

Viral Infections, Non-HIV

Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis

BMJ.

Tricco AC, Zarin W, Cardoso R, Veroniki AA, Khan PA, Nincic V, Ghassemi M, Warren R, Sharpe JP, Page AV, Straus SE

doi: 10.1136/bmj.k4029.

Respiratory Tract Infection

Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling study

Lancet Glob Health.

Roy P, Vekemans J, Clark A, Sanderson C, Harris RC, White RG

doi: 10.1016/S2214-109X(19)30444-9.

Viral Infections, Non-HIV

Insights into the protective effects of influenza vaccination: More hospitalizations but lower follow-up mortality during the 2014/15 influenza season in a Swiss cohort

Vaccine.

Ulyte A, Wei W, Gruebner O, Bähler C, Brüngger B, Blozik E, Dressel H, Schwenkglenks M, von Wyl V

doi: 10.1016/j.vaccine.2020.06.019.

Bacterial InfectionsHIV / AIDS

Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials

Clin Infect Dis.

Campbell JR, Al-Jahdali H, Bah B, Belo M, Cook VJ, Long R, Schwartzman K, Trajman A, Menzies D

doi: 10.1093/cid/ciaa1169.

Related content

Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis

Does BCG Vaccination Protect Against Non-Tuberculous Mycobacterial Infection? A Systematic Review and Meta-Analysis

Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: A population survey-based cross-sectional analysis

Trained innate immunity and resistance to Mycobacterium tuberculosis infection

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons

Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis

Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling study

Insights into the protective effects of influenza vaccination: More hospitalizations but lower follow-up mortality during the 2014/15 influenza season in a Swiss cohort

Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials